The Enterprise Value as of December 2025 (TTM) for Turn Therapeutics Inc. (TTRX) is 122.05M

According to Turn Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 122.05M. This represents a change of -8003.75% compared to the average of -1544248.50 of the last 4 quarters.

Turn Therapeutics Inc. (TTRX) Historical Enterprise Value (quarterly & annually)

How has TTRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Turn Therapeutics Inc. over the last ten years is -953702.00. The current 122.05M Enterprise Value has changed -1279886.88% with respect to the historical average. Over the past ten years (40 quarters), TTRX's Enterprise Value was at its highest in in the June 2024 quarter at 0. The Enterprise Value was at its lowest in in the June 2025 quarter at -3088497.00.

Turn Therapeutics Inc. (TTRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Turn Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Turn Therapeutics Inc. (TTRX) Average Enterprise Value

How has TTRX Enterprise Value performed in the past?

The current Enterprise Value of Turn Therapeutics Inc. (TTRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Turn Therapeutics Inc. (TTRX) Enterprise Value vs. Peers

How is TTRX’s Enterprise Value compared to its peers?

Turn Therapeutics Inc.’s Enterprise Value is greater than Inhibikase Therapeutics, Inc. (75.20M), greater than TuHURA Biosciences, Inc. (92.82M), greater than Seer, Inc. (86.40M), greater than VistaGen Therapeutics, Inc. (78.69M), less than Agenus Inc. (181.50M), greater than Cognition Therapeutics, Inc. (119.19M), greater than Opus Genetics, Inc. (121.30M), greater than Greenwich LifeSciences, Inc. (118.02M), less than Anixa Biosciences, Inc. (154.73M), greater than Tevogen Bio Holdings Inc. (85.88M),

Build a custom stock screener for Turn Therapeutics Inc. (TTRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Turn Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Turn Therapeutics Inc. (TTRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Turn Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.